Intrahepatic cholangiocarcinoma (ICH) is one of the most aggressive malignant neoplasms gastrointestinal tract, which accounts for 10–15% all primary liver tumors. Among risk factors ICH in Europe and Russia, diseases accompanied by formation concretions intrahepatic bile ducts, include Karoli's disease (KD), are importance. The article presents a clinical observation HPV that developed against...

In order to provide early intervention for coronary artery lesion (CAL) caused by Kawasaki Disease (KD), we analyzed clinical characteristics of typical and incomplete KD cases from 1998 to 2008 in Northwest and Central China. A total of 383 patients included 298 cases of typical KD and 85 cases of incomplete KD. The morbidity of incomplete KD was 28.5%, a percentage significantly lower than th...

Coronary artery (CA) abnormalities influence exercise capacity (EC) of patients with Kawasaki disease (KD), and Z-score of CA is a well established method for detecting CA aneurysm. We studied the influence of KD on cardiopulmonary function and EC; meanwhile we analyzed echocardiographic findings of KD patients. We also assessed the correlation between CA Z-score and EC of KD patients to see if...

This paper describes a novel importance sampling method with applications in multimodal optimization. Based on initial results, the method seems suitable for real-time computer vision, and enables an efficient frame-by-frame global search with no initialization step. The method is based on importance sampling with adaptive subdivision, developed by Kajiya, Painter, and Sloan in the context of s...

[1] The diffuse attenuation coefficient for downwelling irradiance (Kd) is an important parameter for ocean studies. For the vast ocean the only feasible means to get fine-scale measurements of Kd is by ocean color remote sensing. At present, values of Kd from remote sensing are estimated using empirical algorithms. Such an approach is insufficient to provide an understanding regarding the vari...

8042 Background: A prespecified interim efficacy analysis of the Phase 3 IKEMA study (NCT03275285) demonstrated that isatuximab (Isa) + carfilzomib (K) and dexamethasone (d) (Isa-Kd) significantly improved progression-free survival (PFS) compared with Kd in patients (pts) relapsed multiple myeloma (RMM) (HR 0.531; 99% CI, 0.318–0.889; P= 0.0007), a clinically meaningful increase minimal residua...